Clinical Characterization of Patients with COVID-19 in Primary Care in Catalonia: Retrospective Observational Study [open pdf - 171KB]
From the Abstract: "The country of Spain has one of the highest incidences of COVID-19 [coronavirus disease 2019], with more than 1,000,000 cases as of the end of October 2020. Patients with a history of chronic conditions, obesity, and cancer are at greater risk from COVID-19; moreover, concerns surrounding the use of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin type II receptor blockers (ARBs) and its relationship to COVID-19 susceptibility have increased since the beginning of the pandemic. [...] The objectives of this study were to compare the characteristics of patients diagnosed with COVID-19 to those of patients without COVID-19 in primary care; to determine the risk factors associated with the outcome of mortality; and to determine the potential influence of certain medications, such as ACEIs [angiotensin-converting-enzyme inhibitors] and ARBs [angiotensin II receptor blockers], on the mortality of patients with COVID-19. [...] We observed that women were more likely to contract COVID-19 than men. In addition, our study did not show that hypertension, obesity, or being treated with ACEIs or ARBs was linked to an increase in mortality in patients with COVID-19. Age is the main factor associated with mortality in patients infected with SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2]." This article can also be found here on the Journal of Medical Internet Research (JMIR) Public Health and Surveillance website: [https://publichealth.jmir.org/2021/2/e25452/].
Miguel Angel Mayer, Josep Vidal-Alaball, Anna Puigdellívol-Sánchez, Francesc X Marín Gomez, Angela Leis, Jacobo Mendioroz Peña. Posted here with permission. Document is under a Creative Commons license and requires proper attribution and noncommercial use to be shared: [https://creativecommons.org/licenses/by/4.0/]
JMIR Public Health and Surveillance: https://publichealth.jmir.org/
JMIR Public Health and Surveillance (2021), v.7 issue 2